What separates life sciences companies that endure from those that fall apart? Dual Fluency explores the critical ability to navigate both the language of science and the language of capital.
Drawing on more than 30 years of experience across M&A, licensing, partnering, and capital raises, this book offers practical insights into leadership, strategy, dealmaking, and the journey from scientific discovery to lasting business value.
Read the book on Amazon: https://a.co/d/0jkY3bDq
